HSA Approval

APO-ATORVASTATIN TABLET 80 MG

Approval Number

SIN14405P

Drug Name

Product Name

APO-ATORVASTATIN TABLET 80 MG

Approval Date

September 5, 2013

Registrant

PHARMAFORTE SINGAPORE PTE LTD

Licence Holder

PHARMAFORTE SINGAPORE PTE LTD

Regulatory Information

Registrant

PHARMAFORTE SINGAPORE PTE LTD

Licence Holder

PHARMAFORTE SINGAPORE PTE LTD

Drug Type

Therapeutic

Forensic Classification

Prescription Only

Formulation Information

Dosage Form

TABLET, FILM COATED

Route of Administration

ORAL

Medical Information

ATC Code

C10AA05

ATC Item Name

atorvastatin

Manufacturer Information

Pharmaceutical Manufacturer

PHARMAFORTE SINGAPORE PTE LTD

Manufacturers

APOTEX INC.

APOTEX INC. (Etobicoke Site)

Active Ingredients

Ingredient Name

ATORVASTATIN CALCIUM PROPYLENE GLYCOL SOLVATE 88MG EQV ATORVASTATIN

Strength

80 MG

Drug MonographAtorvastatin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

APO-ATORVASTATIN TABLET 80 MG - HSA Approval | MedPath

AI-Powered Research

Premium Access

APO-ATORVASTATIN TABLET 80 MG

Regulatory Information

Formulation Information

Medical Information

Manufacturer Information

Active Ingredients

MedPath

Product

Company

Legal